Product
Supplier
Encyclopedia
Inquiry
Home > Encyclopedia > Iguratimod

Iguratimod

pharmaceutical raw materials
Iguratimod structure

Iguratimod 

structure
  • CAS No:

    123663-49-0

  • Formula:

    C17H14N2O6S

  • Chemical Name:

    Iguratimod

  • Synonyms:

    Methanesulfonamide,N-[3-(formylamino)-4-oxo-6-phenoxy-4H-1-benzopyran-7-yl]-;N-[3-(Formylamino)-4-oxo-6-phenoxy-4H-1-benzopyran-7-yl]methanesulfonamide;T 614;3-Formylamino-7-methylsulfonylamino-6-phenoxy-4H-1-benzopyran-4-one;Iguratimod;N-[3-(Formylamino)-4-oxo-6-phenoxy-4H-chromen-7-yl]methanesulfonamide;T 614 (antiinflammatory);Careram;Kolbet

  • Categories:

    Active Pharmaceutical Ingredients  >  Antipyretic Analgesics

Description

In August 2011, China’s State FDA approved Simcere Pharmaceutical Group’s new drug application for iguratimod (T-614), a disease modifying anti-rheumatic drug (DMARD) for the treatment of rheumatoid arthritis (RA). Preclinical in vivo studies indicated that iguratimod was effective in an established adjuvant-induced arthritis model (ED40=3.6 mg/kg) in rats and also efficacious in a type II collagen-induced arthritis model in DBA/1J mice at 30 mg and 100 mg/kg.


Iguratimod is an organic molecular entity.|Iguratimod is under investigation in Rheumatoid Arthritis.

Iguratimod Basic Attributes

374.37

374.37

1308068-626-2

4IHY34Y2NV

DTXSID0048971

2935009090

Characteristics

119

1.4

1.52±0.1 g/cm3(Predicted)

238.0 to 242.0 °C

580.6±60.0 °C(Predicted)

304.9±32.9 °C

1.674

Safety Information

P201, P202, P281, P308+P313, P405, P501

H361

|Warning|H361 (100%): Suspected of damaging fertility or the unborn child [Warning Reproductive toxicity]|P201, P202, P281, P308+P313, P405, and P501|The GHS information provided by 1 company from 1 notification to the ECHA C&L Inventory.

Drug Information

3-formylamino-7-methylsulfonylamino-6-phenoxy-4H-1-benzopyran-4-one

Iguratimod Use and Manufacturing

Iguratimod acts as an anti-inflammatory agent, used primarily in the treatment of rheumatoid arthritis.

Computed Properties

Molecular Weight:374.4
XLogP3:1.4
Hydrogen Bond Donor Count:2
Hydrogen Bond Acceptor Count:7
Rotatable Bond Count:5
Exact Mass:374.05725734
Monoisotopic Mass:374.05725734
Topological Polar Surface Area:119
Heavy Atom Count:26
Complexity:665
Covalently-Bonded Unit Count:1
Compound Is Canonicalized:Yes

Drug Function and Efficacy

It can inhibit foot swelling in collagen arthritis model rats and alleviate the destruction of rat bone and cartilage tissue; it can inhibit the activity of nuclear factor-κB (NF-κB) in vitro, thereby inhibiting the production of inflammatory cytokines; it can directly interact with mouse and human B cells in vitro to inhibit the production of immunoglobulins; it can inhibit the activity of purified cyclooxygenase-2 (COX-2) in vitro (IC50=7.7μg/ml), but has no effect on the activity of cyclooxygenase-1 (COX-1).

This ingredient has been used in drugs with the following functions (note: it does not mean that the ingredient itself has the following health functions)

Related Drugs

Registered Holders

  • Zhejiang Hengkang Pharmaceutical Co., Ltd.

    China China
    Active
  • TianJin TaiPu Pharmaceutical Co., Ltd.

    China China
    Active
  • CHEER FINE Pharmaceutical Co., Ltd.

    China China
    Active

Recommended Suppliers of Iguratimod

Scan the QR Code to Share

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.